US 10512673
Use of peptide-based inhibitors of the stat3-IL10 pathway for treating bacterial infection and granulomatous disease
granted A61KA61K38/1709A61K38/1793
Quick answer
US patent 10512673 (Use of peptide-based inhibitors of the stat3-IL10 pathway for treating bacterial infection and granulomatous disease) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Dec 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Dec 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K38/1709, A61K38/1793, A61K38/2066, A61K45/06